GDC-0973 (Cobimetinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GDC-0973 (Cobimetinib), covering 2016-06-17 to 2016-06-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma [Phase 1]